Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
about
Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis.Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort studyFibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.Late presentation of chronic viral hepatitis for medical care: a consensus definitionAlcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver DiseasesPrevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.The Role of M30 in Predicting the Severity of Liver Fibrosis and Inflammation in Chronic Hepatitis B PatientsIncreased hepatocellular carcinoma risk in chronic hepatitis B patients with persistently elevated serum total bile acid: a retrospective cohort study.Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma.Noninvasive scoring system for significant inflammation related to chronic hepatitis B.Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B.Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China.Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection.Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B.Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.Serum WFA+ -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection.A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B.Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study.Combining GP73 with liver stiffness measurements: A proof-of-concept for non-invasive fibrosis assessment in antiviral-naïve HBV patients.Development and validation of a model for staging hepatic fibrosis for chronic hepatitis B patients with E antigen-positive.Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients.Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease.Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure.Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences-Authors' reply.Reply to Huang et al.Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapy.Ultrasound findings in autoimmune hepatitis.Noninvasive Biomarkers in Assessment of Liver Fibrosis in Patients with HBeAg Negative Chronic Hepatitis B.Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B
P2860
Q26740195-2EEFFF7C-7D15-4BA6-AD91-23783630F072Q30354346-777C3117-A44B-4E52-9C02-2CD2697DDC48Q30359561-620B3529-9AF8-4F71-97A5-B90142154E3EQ30362068-80D0F458-FC50-4701-8AB0-B847F5CD8F76Q33630076-C869E701-26B2-4C58-831D-EAFD7F136AC9Q33787607-903E1CA8-C8EE-4B8C-A91C-E1C0571703C4Q33852130-6D23714E-6E59-4266-BE9F-10A4498FE16CQ37305541-A7332AA1-1297-46DF-BF41-0E6FABA4D39EQ37330550-463257B1-0D74-4099-8B0B-092405C608D7Q37383901-52D8EF11-79FA-4962-82D9-83BC97EA1F49Q37460011-B14C860A-0A74-48CA-B010-4407A5B6E094Q37467907-CE0FCFB2-ACE8-424E-9C1A-3FCB2F7CAB6FQ37692297-C054BF40-39ED-4914-AC27-2E83BB8C7C1EQ39152779-14178AC8-683C-4D1B-9102-3F5D0793E870Q40089026-8795BD5A-9AC1-4BC9-8B4E-C6C02FE36341Q40096016-F2E42BEF-344C-4A77-A2A9-CE3061C42A64Q40172883-11706738-F7A9-456A-AE2C-4F4F46367F52Q40238088-D7544B4E-732E-49B3-82C2-0EC7AF4BE98BQ40259385-8956767D-CECA-436E-B58D-6BA4E915241FQ40355176-4F701D8C-D2B6-4D0F-8479-3A918528AD07Q40409098-BAC16285-73BB-42B4-9CAD-830B763FBB9DQ40701776-2999B9A0-E0B5-4B87-BB3F-9AD6BF6E6491Q41708878-20BDA5D0-6F89-46C9-8A76-AC98AC3E880BQ42049084-1170763F-33EA-4FBB-82D1-626400DC50A6Q45873545-A936DBEA-337F-4630-AD21-41AD81B78360Q47148411-B2A7067C-1E80-4F18-9D76-2724909AB647Q47153317-43C94C95-26A6-430D-AEE3-D900BB06F1CFQ47223995-5A1F72B0-4EED-41DD-9359-699EF13B32E1Q47554076-DC5FF3F9-0F64-4428-91B2-9454E316BFFAQ47589332-2E033C26-E7A5-454D-9515-13E21A218004Q47695757-B31A7BD8-E5A3-4911-97A8-16184A55303FQ48228680-8641F61C-1497-403E-8FC3-AE5FF5D9F0BBQ50218882-68D0E5DE-6AD5-4742-8C02-8E166695ED12Q50294551-C63E1774-035C-4F37-8F1B-1A966AA2D9E2Q55261642-E1104ED2-EE3F-4FE9-B7D8-8BB674EAA180Q55491282-38F878C2-A25F-4BE8-B85B-A66D7FA08B63Q58551532-02CBDB98-D0C7-4ACB-A57A-DDD53A19DB72
P2860
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of APRI and FIB-4 s ...... chronic hepatitis B patients.
@en
type
label
Evaluation of APRI and FIB-4 s ...... chronic hepatitis B patients.
@en
prefLabel
Evaluation of APRI and FIB-4 s ...... chronic hepatitis B patients.
@en
P2093
P50
P1476
Evaluation of APRI and FIB-4 s ...... n chronic hepatitis B patients
@en
P2093
Harry L A Janssen
Jeffrey D Bornstein
Jörg Petersen
Leland J Yee
Maria Buti
Patrick Marcellin
Phillip Dinh
Raul E Aguilar Schall
Rohit Loomba
P304
P356
10.1016/J.JHEP.2015.11.012
P577
2015-12-02T00:00:00Z